NFKB1 and gastric cancer: Our group has also reported that isorhamnetin, a methylated metabolite of dietary flavonoid quercetin, can abrogate the activation of master transcription factor NF-κB [67,68,69,70,71,72] and thus significantly enhance the anti-tumoral effects of capecitabine in gastric cancer xenograft mouse model [72].